TotalMarketCap

Market cap

$107.458 B

$921.67 +0.68%

Close of 7 Oct 2026

As of 7 Oct 2026, McKesson (MCK) has a market capitalization of $107.5B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$403.4B

#5 by revenue

Earnings

$4.76B

#105 by earnings

Shares outstanding

116,590,363

Latest filing cover page

P/E ratio

22.6

Cap ÷ net income

Other Pharmaceuticals, ranked by market cap

All 10 →
  1. #1McKessonMCK$107.5B
  2. #2CencoraCOR$60.4B
  3. #3Cardinal HealthCAH$54.1B
  4. #4HerbalifeHLF$1.32B
  5. #5Nu Skin EnterprisesNUS$230.7M

What if McKesson were worth as much as…

Open the what-if tool →

Or at a round number

Where these numbers come from

Share counts and financials for McKesson are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 8 Oct 2026. Read the methodology.